Obinutuzumab With ICE Chemotherapy Well Tolerated in Young Patients With Burkitt Lymphoma

American Society of Pediatric Hematology/Oncology 2022: Study investigated Obinutuzumab combined with chemotherapy for treatment of Burkitt lymphoma in young patients.